LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration

HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots

Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832

Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305

Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences

Mitchell, R., Beitzel, B. F., Schröder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 1,002

Alu Repeats and Human Disease

Deininger, P. L., & Batzer, M. A. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2864 · Cited by 911

Inducible gene targeting in mice using the Cre/lox system.

Sauer, B. (1998) · Methods · doi:10.1006/meth.1998.0593 · Cited by 858

HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells

Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704

A role for LEDGF/p75 in targeting HIV DNA integration

Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658

HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer

Engelman, A., Mizuuchi, K., & Craigie, R. (1991) · Cell · doi:10.1016/0092-8674(91)90297-c · Cited by 655

An essential role for LEDGF/p75 in HIV integration

Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W., & Poeschla, E. M. (2006) · Science · doi:10.1126/science.1132319 · Cited by 537

Breaking barriers to transcription elongation

Saunders, A., Core, L. J., & Lis, J. T. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1981 · Cited by 525

TRACE generates fluorescent human reporter cell lines to characterize epigenetic pathways

Tchasovnikarova, I. A., Marr, S. K., Damle, M., & Kingston, R. E. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.11.035 · Cited by 12

Tough Way In, Tough Way Out: The Complex Interplay of Host and Viral Factors in Nucleocytoplasmic Trafficking during HIV-1 Infection

Sarkar, S., Balakrishnan, K., Chintala, K., Mohareer, K., Luedde, T., Vasudevan, A. A. J., Münk, C., & Banerjee, S. (2022) · Viruses · doi:10.3390/v14112503 · Cited by 13

Repair of Oxidative DNA Base Damage in the Host Genome Influences the HIV Integration Site Sequence Preference

Bennett, G. R., Peters, R., Wang, X., Hanne, J., Sobol, R. W., Bundschuh, R. A., Fishel, R. A., & Yoder, K. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103164 · Cited by 12

Targeting Cellular Cofactors in HIV Therapy

Dürr, R., Keppler, O. T., Christ, F., Crespan, E., Garbelli, A., Maga, G., & Dietrich, U. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_45 · Cited by 12

The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir

Dinh, T., Tber, Z., Rey, J. S., Mengshetti, S., Annamalai, A. S., Haney, R., Briganti, L., Amblard, F., Fuchs, J. R., Cherepanov, P., et al. (2024) · mBio · doi:10.1128/mbio.00465-24 · Cited by 12

Identification of small peptides inhibiting the integrase‐LEDGF/p75 interaction through targeting the cellular co‐factor

Cavalluzzo, C., Christ, F., Voet, A. R. D., Sharma, A. K., Singh, B. K., Zhang, K. Y. J., Lescrinier, E., Maeyer, M. D., Debyser, Z., & der Eycken, E. V. V. (2013) · Journal of Peptide Science · doi:10.1002/psc.2543 · Cited by 11

Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization

Eilers, G., Gupta, K., Allen, A., Montermoso, S., Murali, H., Sharp, R. B., Hwang, Y., Bushman, F. D., & Duyne, G. D. V. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011097 · Cited by 11

In Search of Second-Generation HIV Integrase Inhibitors: Targeting Integration Beyond Strand Transfer

Voet, A. R. D., Maeyer, M. D., Debyser, Z., & Christ, F. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.86 · Cited by 11

Removal of nuclease contamination during purification of recombinant prototype foamy virus integrase

Lopez, M. A., Mackler, R. M., & Yoder, K. E. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.06.002 · Cited by 11

Transcription Factor YY1 Interacts with Retroviral Integrases and Facilitates Integration of Moloney Murine Leukemia Virus cDNA into the Host Chromosomes

Inayoshi, Y., Okino, Y., Miyake, K., Mizutani, A., Yamamoto-Kishikawa, J., Kinoshita, Y., Morimoto, Y., Imamura, K., Morshed, M., Kono, K., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02681-09 · Cited by 12

Biochemical and biophysical analyses of concerted (U5/U3) integration

Grandgenett, D. P., Bera, S., Pandey, K. K., Vora, A. C., Zahm, J. A., & Sinha, S. (2008) · Methods · doi:10.1016/j.ymeth.2008.11.002 · Cited by 11

Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors

Sun, J., & Kessl, J. J. (2024) · Viruses · doi:10.3390/v16020200 · Cited by 10

The Complex Interactions Between HIV-1 and Human Host Cell Genome: From Molecular Mechanisms to Clinical Practice

Tolomeo, M., Tolomeo, F., & Cascio, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073184 · Cited by 10

Heterogeneity of HIV-1 latent reservoirs

Zhao, J., & Deng, K. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001085 · Cited by 11

G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential

Ajoge, H. O., Kohio, H. P., Paparisto, E., Coleman, M. D., Wong, K., Tom, S. K., Bain, K. L., Berry, C. C., Arts, E. J., & Barr, S. D. (2022) · Viruses · doi:10.3390/v14112494 · Cited by 10

Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice

Wang, H., Shun, M.-C., Dickson, A. K., & Engelman, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137797 · Cited by 11

Nucleosome DNA unwrapping does not affect prototype foamy virus integration efficiency or site selection

Mackler, R. M., Jones, N. D., Gardner, A. M., Lopez, M. A., Howard, C. J., Fishel, R. A., & Yoder, K. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212764 · Cited by 10

Targeting Protein–Protein Interactions for HIV Therapeutics

Rice, A. P., & Sutton, R. E. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.369 · Cited by 10

Identification of low molecular weight nuclear complexes containing integrase during the early stages of HIV-1 infection

Gérard, A., Soler, N., Ségéral, E., Belshan, M., & Emiliani, S. (2013) · Retrovirology · doi:10.1186/1742-4690-10-13 · Cited by 12

Efficient transduction of LEDGF/p75 mutant cells by complementary gain-of-function HIV-1 integrase mutant viruses

Wang, H., Shun, M.-C., Li, X., Nunzio, F. D., Hare, S., Cherepanov, P., & Engelman, A. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2013.2 · Cited by 11

Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase

Agharbaoui, F. E., Hoyte, A. C., Ferro, S., Gitto, R., Buemi, M. R., Fuchs, J. R., Kvaratskhelia, M., & Luca, L. D. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.077 · Cited by 11

HIV-1 Integrase Inhibition: Looking at Cofactor Interactions

Christ, F., & Debyser, Z. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.162 · Cited by 10

Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors

Dinh, L. P., Sun, J., Glenn, C. D., Patel, K., Pigza, J. A., Donahue, M. G., Yet, L., & Kessl, J. J. (2022) · Viruses · doi:10.3390/v14071466 · Cited by 9

The discovery and development of RNA-based therapies for treatment of HIV-1 infection

Chen, M. J., Gatignol, A., & Scarborough, R. J. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2117296 · Cited by 9

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia

Demoen, L., Matthijssens, F., Reunes, L., Palhais, B., Lintermans, B., T’Sas, S., Fijałkowski, I., Taminau, J., Akele, M. Z., Belle, S. V., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado6765 · Cited by 9

Alteration of select gene expression patterns in individuals infected with HIV‐1

Serrao, E., Wang, C., Frederick, T., Lee, C.-L., Anthony, P., Arribas-Layton, D., Baker, K., Millstein, J., Kovács, A., & Neamati, N. (2014) · Journal of Medical Virology · doi:10.1002/jmv.23872 · Cited by 9

HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities

Nilavar, N. M., & Raghavan, S. C. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107515 · Cited by 9

Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment

Svensson, J. P. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668637 · Cited by 9

Host Factors in Retroviral Integration and the Selection of Integration Target Sites

Craigie, R., & Bushman, F. D. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch45 · Cited by 10

Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection

Pellaers, E., Bhat, A., Christ, F., & Debyser, Z. (2022) · Viruses · doi:10.3390/v15010032 · Cited by 8

The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration

Marquis, K. A., Everett, J. K., Cantu, A., McFarland, A. G., Sherrill-Mix, S. A., Krystal, M., Parcella, K. E., Gillis, E. P., Fridell, R. A., & Bushman, F. D. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0161 · Cited by 8

Proteomic analysis of H3K36me3 and PSIP1/p75 (LEDGF) complexes reveal their wider role in DNA repair

Pradeepa, M. M., Taylor, G. C. A., & von Kriegsheim, A. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.11589.1 · Cited by 8

HIV-1 Integrase Drug Discovery Comes of Age

Demeulemeester, J., Maeyer, M. D., & Debyser, Z. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_33 · Cited by 8

Methods for the Analyses of Inhibitor-Induced Aberrant Multimerization of HIV-1 Integrase

Kessl, J. J., Sharma, A., & Kvaratskhelia, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3046-3_10 · Cited by 8

Integrase anchors viral RNA to the HIV-1 capsid interior

Singer, M. R., Li, Z., Rey, J. S., Hope, J., Chenavier, F., Cook, N., Punch, E. K., Smith, J., Zhou, Z., Maslen, S., et al. (2026) · Nature · doi:10.1038/s41586-026-10154-x · Cited by 8

Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses

Kohio, H. P., Ajoge, H. O., Coleman, M. D., Ndashimye, E., Gibson, R. M., Arts, E. J., & Barr, S. D. (2023) · Viruses · doi:10.3390/v15020465 · Cited by 7

Help or Hinder: Protein Host Factors That Impact HIV-1 Replication

Moezpoor, M. R., & Stevenson, M. (2024) · Viruses · doi:10.3390/v16081281 · Cited by 7

BET-Independent Murine Leukemia Virus Integration Is Retargeted In Vivo and Selects Distinct Genomic Elements for Lymphomagenesis

Nombela, I., Michiels, M., Looveren, D. V., Marcelis, L., Ashkar, S. E., Belle, S. V., Bruggemans, A., Tousseyn, T., Schwaller, J., Christ, F., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01478-22 · Cited by 7

Brief Histories of Retroviral Integration Research and Associated International Conferences

Grandgenett, D. P., & Engelman, A. (2024) · Viruses · doi:10.3390/v16040604 · Cited by 7

Nondividing Cells: A Safer Bet for Integrating Vectors?

Brady, T., & Bushman, F. D. (2011) · Molecular Therapy · doi:10.1038/mt.2011.40 · Cited by 7

Three-Fragment Fluorescence Complementation for Imaging of Ternary Complexes under Physiological Conditions

Chen, M., Li, W., Zhang, Z., Pan, J., Sun, Y., Zhang, X., Zhang, X., & Cui, Z. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02661 · Cited by 7

Accumulation of long-term transcriptionally active integrated retroviral vectors in active promoters and enhancers

Šenigl, F., Miklík, D., Auxt, M., & Hejnar, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx889 · Cited by 7

Prototype foamy virus integrase is promiscuous for target choice

Mackler, R. M., Lopez, M. A., Osterhage, M. J., & Yoder, K. E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.031 · Cited by 7

Targeting HIV-1 DNA integration by swapping tethers

Craigie, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915097107 · Cited by 7

HIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin

Astiazaran, P., Bueno, M. T. D., Morales, E., Kugelman, J. R., Garcia-Rivera, J. A., & Llano, M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-27 · Cited by 7

Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication

Xu, Z., Zheng, Y., Ao, Z., Clément, M., Mouland, A. J., Kalpana, G. V., Belhumeur, P., Cohen, É. A., & Yao, X. (2008) · Retrovirology · doi:10.1186/1742-4690-5-102 · Cited by 7

Species-Specific Urothelial Toxicity With an Anti-HIV Noncatalytic Site Integrase Inhibitor (NCINI) Is Related to Unusual pH-Dependent Physicochemical Changes

Roberts, R. A., Campbell, R. A., Sikakana, P., Sadler, C., Osier, M. R., Xu, Y., Feng, J. Y., Mitchell, M. L., Sakowicz, R., Chester, A. E., et al. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab073 · Cited by 6

The Involvement of Ubiquitination and SUMOylation in Retroviruses Infection and Latency

Liang, T., Li, G., Lu, Y., Hu, M., & Ma, X. (2023) · Viruses · doi:10.3390/v15040985 · Cited by 6

Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead

Plaza-Jennings, A. L., & Akbarian, S. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00675-9 · Cited by 6

Retroviral prototype foamy virus intasome binding to a nucleosome target does not determine integration efficiency

Kotlar, R. M., Jones, N. D., Senavirathne, G., Gardner, A. M., Messer, R. K., Tan, Y. Y., Rabe, A. J., Fishel, R. A., & Yoder, K. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100550 · Cited by 6

Prototype Foamy Virus Integrase Displays Unique Biochemical Activities among Retroviral Integrases

Rabe, A. J., Tan, Y. Y., Larue, R. C., & Yoder, K. E. (2021) · Biomolecules · doi:10.3390/biom11121910 · Cited by 6

Rapid In Vitro Evaluation of Antiretroviral Barrier to Resistance at Therapeutic Drug Levels

Mulato, A. S., Hansen, D., Thielen, A., Porter, D., Stepan, G. J., White, K., Daeumer, M., Cihlář, T., & Yant, S. R. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0071 · Cited by 6

LEDGF/p75 and Transportin-SR2 are Cellular Cofactors of HIV Integrase and Novel Targets for Antiviral Therapy

Thys, W., Busschots, K., McNeely, M., Voet, A. R. D., Christ, F., & Debyser, Z. (2009) · HIV Therapy · doi:10.2217/17584310.3.2.171 · Cited by 6

Retroviral Replication

Pedersen, F. S., Pyrz, M., & Duch, M. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0000430.pub3 · Cited by 8

Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication

Jehad, M. A., Ali, L. M., Pillai, V. N., Prabhu, S. G., Mustafa, F., & Rizvi, T. A. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf066 · Cited by 5

HIV-1 Integration into Chromatin: New Insights and Future Perspectives

Lesbats, P., Lavigne, M., & Parissi, V. (2011) · Future Virology · doi:10.2217/fvl.11.84 · Cited by 7

Defining Pharmacological Targets by Analysis of Virus–Host Protein Interactions

Llano, M., & Peña-Hernández, M. A. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.11.001 · Cited by 6

The Impact of Lens Epithelium-Derived Growth Factor p75 Dimerization on Its Tethering Function

Brouns, T., Lux, V., Belle, S. V., Christ, F., Veverka, V., & Debyser, Z. (2024) · Cells · doi:10.3390/cells13030227 · Cited by 5

Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation

Röling, M. D., Stoszko, M., & Mahmoudi, T. (2016) · InTech eBooks · doi:10.5772/61948 · Cited by 6

Shifting Retroviral Vector Integrations Away from Transcriptional Start Sites via DNA-Binding Protein Domain Insertion into Integrase

Nam, J.-S., Lee, J.-E., Lee, K.-H., Yang, Y., Kim, S.-H., Bae, G., Noh, H., & Lim, K. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.11.001 · Cited by 5

Lessons from Viral Latency in T Cells: Manipulating HIV-1 Transcription by Sirna

Suzuki, K., & Kelleher, A. D. (2010) · HIV Therapy · doi:10.2217/hiv.10.1 · Cited by 5

A DNA-origami nuclear pore mimic reveals nuclear entry mechanisms of HIV-1 capsidPreprint

Shen, Q., Xu, C., Jang, S., Xiong, Q., Devarkar, S. C., Tian, T., Bedwell, G. J., Tripler, T. N., Hu, Y., Yuan, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.10.245522 · Cited by 6

Deciphering the Effects of Pterocarpus mildbraedii and Pterocarpus soyauxii Against Sars-CoV-2 and HIV Coinfection through the Integration of ADMET, Network Pharmacology, in silico Molecular Docking, Pharmacophore Analysis and Computational Inhibition of CDK2 and HIV-1 Viral Proteins

Owona, P. E., Sandrine, M. N. Y., Ronald, B. A. G., Bilanda, D. C., Camille, N. S. M., Désiré, D. D. P., Mohamed, R. A. E. H., Alwethaynani, M. S., Al-Hoshani, N., Binsaleh, A. Y., et al. (2025) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416526500390 · Cited by 4

The emerging roles of ubiquitin-like modifications in regulating HIV replication and host defense

Yuan, J., Wang, H., Sun, X., & Huan, C. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1593445 · Cited by 5

Molecular mechanisms by which the HIV-1 latent reservoir is established and therapeutic strategies for its elimination

Chvatal‐Medina, M., López-Guzmán, C., Díaz, F. J., Gallego-Quintero, S., Rugeles, M. T., & Taborda, N. A. (2023) · Archives of Virology · doi:10.1007/s00705-023-05800-y · Cited by 4

L368F/V408F double mutant of IBD of LEDGF/p75 retains interaction with M178I mutant of HIV-1 integrase

George, A., & Raghavendra, N. K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.035 · Cited by 4

Association of Single Nucleotide Polymorphisms in the Lens Epithelium-Derived Growth Factor (LEDGF/p75) with HIV-1 Infection Outcomes in Brazilian HIV-1+ Individuals

Passaes, C., Cardoso, C. C., Caetano, D. G., Teixeira, S. L. M., Guimarães, M. L., Campos, D. P., Veloso, V. G., Babič, D. Z., Stevenson, M., Moraes, M. O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101780 · Cited by 4

Validation of host factors of HIV integration as novel drug targets for anti-HIV therapy

Debyser, Z., Desimmie, B. A., Taltynov, O., Demeulemeester, J., & Christ, F. (2014) · MedChemComm · doi:10.1039/c3md00302g · Cited by 4

Covalent Inhibition of HIV‐1 Integrase by N‐Succinimidyl Peptides

Chandra, K., Das, P., Samarasimhareddy, M., Hurevich, M., Iosub‐Amir, A., Metanis, N., Reches, M., & Friedler, A. (2016) · ChemMedChem · doi:10.1002/cmdc.201600190 · Cited by 4

Advances in Molecular Retrovirology

Saxena, S. K. (2016) · InTech eBooks · doi:10.5772/60583 · Cited by 4

Cellular Cofactors of HIV Integration

Thys, W., Bartholomeeusen, K., Debyser, Z., & Rijck, J. D. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch9 · Cited by 4

The role of chromatin in retroviral preintegration complex function

Sapp, N., Prakash, P., Chakraborty, R., Balasubramaniam, M., & Dash, C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110440 · Cited by 3

Perspectives of Genome-Editing Technologies for HIV Therapy

Ebina, H., Gee, P., & Koyanagi, Y. (2015) · Current HIV Research · doi:10.2174/1570162x13666150807105718 · Cited by 3

Polymorphic LEDGF/p75 variants support efficient HIV-1 infection ex vivo

Koh, Y., Ballana, E., Esté, J. A., & Engelman, A. (2013) · AIDS · doi:10.1097/qad.0b013e32835af34c · Cited by 3

Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity

Tocco, G., Canton, S., Laus, A., Caboni, P., Grice, S. F. J. L., Tramontano, E., & Esposito, F. (2023) · Molecules · doi:10.3390/molecules28186700 · Cited by 3

Effective prediction model and determination of binding residues influential for inhibitors targeting HIV-1 integrase-LEDGF/p75 interface by employing solvent accessible surface area energy as key determinant

Thangsunan, P., Wongsaipun, S., Kittiwachana, S., & Suree, N. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1580219 · Cited by 3

Foamy Virus Integrase in Development of Viral Vector for Gene Therapy

Kim, J., Lee, G., & Shin, C. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2003.03046 · Cited by 3

The Design of New HIV-IN Tethered Bifunctional Inhibitors Using Multiple Microdomain Targeted Docking

Ciubotaru, M., Musat, M. G., Surleac, M. D., Ionita, E., Petrescu, A., Abele, E., & Abele, R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180406114405 · Cited by 3

Molecular Biology of HIV: Implications for New Therapies

Greene, W. C., & Peterlin, B. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2882-6.50007-1 · Cited by 3

Retroviral DNA Transposition: Themes and Variations

Skalka, A. M. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch48 · Cited by 3

Absence of LEDGF/p75 Expression in Astrocytes May Affect HIV-1 Integration Efficiency

Yoder, K. E. (2019) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416819020113 · Cited by 2

Peptide fibrils as monomer storage of the covalent HIV‐1 integrase inhibitor

Chandra, K., Das, P., Metanis, N., Friedler, A., & Reches, M. (2017) · Journal of Peptide Science · doi:10.1002/psc.2959 · Cited by 2

Relationship between the distribution of LEDGF along genes and positions of HIV-1 DNA integration

Pathak, R., Esnault, C., Radhakrishnan, R., Singh, P. K., Zhang, H., Dale, R., Anand, A., Mitra, A., Bedwell, G. J., Engelman, A., et al. (2026) · mBio · doi:10.1128/mbio.00090-26 · Cited by 2

Molecular Crosstalk between HIV-1 Integration and Host Proteins – Implications for Therapeutics

Suzuki, Y., Suzuki, Y., & Yamamoto, N. (2011) · InTech eBooks · doi:10.5772/23095 · Cited by 2

Nuclear Pore Complexes, Genome Organization and HIV-1 Infection

Nunzio, F. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-71614-5_8 · Cited by 2

Protein-Protein Interaction Targets to Inhibit HIV-1 Infection

Kadow, J. F., Langley, D. R., Meanwell, N. A., Pracitto, R., Walker, M. A., & Yeung, K. (2012) · Topics in medicinal chemistry · doi:10.1007/978-3-642-28965-1_4 · Cited by 2

Retroviral Integration Target Site Selection

Ciuffi, A., & Bushman, F. D. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch5 · Cited by 2

Mechanistic and pharmacological analyses of HIV-1 integration

Engelman, A. (2009) · Methods · doi:10.1016/j.ymeth.2009.03.018 · Cited by 2

A CRISPR-Cas9 Genome Engineering Platform in Primary CD4+ T Cells for the Interrogation of HIV Host FactorsPreprint

Hultquist, J. F., Hiatt, J. B., Schumann, K., McGregor, M., Roth, T. L., Haas, P., Doudna, J. A., Marson, A., & Krogan, N. J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/205500 · Cited by 2

Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Import in Non-Dividing CellsPreprint

Opp, S., Martínez‐López, A., Fricke, T., Buffone, C., Severgnini, M., Cifola, I., Frabetti, S., Skorupka, K. A., Zadrozny, K. K., Ganser‐Pornillos, B. K., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155897 · Cited by 2

Genomic profiling of HIV-1 integration in microglia links viral insertions to TAD organizationPreprint

Rheinberger, M., Costa, A. L., Kampmann, M., Glavaš, D., Shytaj, I. L., Penzo, C., Tibroni, N., Fackler, O., Vlahoviček, K., Lucic, B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.14.480322 · Cited by 2

Disruption of LEDGF/p75-directed integration derepresses antisense transcription of the HIV-1 genomePreprint

Tedbury, P. R., Mahboubi, D., Puray‐Chavez, M., Shah, R., Ukah, O. B., Wahoski, C. C., Fadel, H. J., Poeschla, E. M., Gao, X., McFadden, W. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.06.627169 · Cited by 2

Gene therapy to cure HIV infection

Goguen, R. P., Chen, M. J., Dunkley, O. R. S., Gatignol, A., & Scarborough, R. J. (2023) · Virologie · doi:10.1684/vir.2023.1021 · Cited by 1

Early pandemic HIV-1 integration site preferences differ across anatomical sites

Kohio, H. P., Ajoge, H. O., Barua, E. A., Vajaria, N. R., Wu, I. K. F., Coleman, M. D., Tom, S. K., van der Meer, F. J. U. M., Gill, M. J., Church, D. L., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01146-5 · Cited by 1

HIV-1 uncoating location dictates sites of integration

Burdick, R. C., Patro, S. C., Bare, E. K., Siddiqui, R., Delviks‐Frankenberry, K. A., Nikolaitchik, O. A., Hughes, S. H., Wu, X., Hu, W.-S., & Pathak, V. K. (2026) · Nature Communications · doi:10.1038/s41467-026-71679-3 · Cited by 1

Core nucleosomes are refractory to lentiviral DNA integration

Hope, J., Punch, E. K., Cook, N., Singer, M. R., Joshi, D., Singh, P. K., Nans, A., Sweeney, N. P., Vanderlinden, W., Engelman, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76698-8 · Cited by 1

Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cells

Tada, T., Kadoki, M., Liu, Y., Tokunaga, K., & Iwakura, Y. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00377 · Cited by 1

Approaches to site-directed DNA integration based on transposases and retroviral integrases

Knyazhanskaya, E. S., Кондрашина, О. В., & Gottikh, M. (2011) · Molecular Biology · doi:10.1134/s0026893311060069 · Cited by 1

Cold spots in hot spots: transcription start sites of active genes are spared from HIV vector integration

Giordano, F. A., Appelt, J. U., Zucknick, M., Abba, M. L., Zeller, W. J., Früehauf, S., Allgayer, H., & Laufs, S. (2009) · AIDS · doi:10.1097/qad.0b013e3283336432 · Cited by 1

Monitoring HIV-1 Nuclear Import Kinetics Using a Chemically Induced Nuclear Pore Blockade Assay

Dharan, A., & Campbell, E. M. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3862-0_10 · Cited by 1

The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication

Engelman, A., & Cherepanov, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000046 · Cited by 231

Review The Lentiviral Integrase Binding Protein LEDGF/p75 and HIV-1 Replication

Engelman, A., & Cherepanov, P. (2013)

Virus Evolution Reveals an Exclusive Role for LEDGF/p75 in Chromosomal Tethering of HIV

Hombrouck, A., Rijck, J. D., Hendrix, J., Vandekerckhove, L., Voet, A. R. D., Maeyer, M. D., Witvrouw, M., Engelborghs, Y., Christ, F., Gijsbers, R., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030047 · Cited by 129

A role for LEDGF/p75 in targeting HIV DNA integration

Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658

Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus

Vandekerckhove, L., Christ, F., Maele, B. V., Rijck, J. D., Gijsbers, R., den Haute, C. V., Witvrouw, M., & Debyser, Z. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1886-1896.2006 · Cited by 210